These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2792459)

  • 1. [Growth hormone response to arginine administration in diabetics--with special reference to the multiple regression analysis in association with diabetic retinopathy].
    Kitada M; Yasuda K; Takeda N; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1989 Jun; 65(6):558-71. PubMed ID: 2792459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and clinical applications of measurement of urinary growth hormone in diabetic subjects.
    Suzuki K; Miyata H; Suzuki T; Kajinuma H
    Diabetes; 1989 Dec; 38(12):1567-72. PubMed ID: 2684712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A glimpse of the 'natural history' of established type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis.
    Coates PA; Ollerton RL; Luzio SD; Ismail I; Owens DR
    Diabetes Res Clin Pract; 1994 Dec; 26(3):177-87. PubMed ID: 7736898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Altered responses of heart rate, renal sodium handling and plasma growth hormone to clonidine in type II diabetic patients].
    Tanaka K
    Nihon Naibunpi Gakkai Zasshi; 1992 Nov; 68(11):1177-87. PubMed ID: 1334889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exaggerated growth hormone response to growth hormone-releasing hormone in type I diabetes mellitus.
    Krassowski J; Felber JP; Rogala H; Jeske W; Zgliczynski S
    Acta Endocrinol (Copenh); 1988 Feb; 117(2):225-9. PubMed ID: 3132790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.
    Suguro T; Watanabe T; Kodate S; Xu G; Hirano T; Adachi M; Miyazaki A
    Clin Sci (Lond); 2008 Dec; 115(11):327-34. PubMed ID: 18338983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus.
    Martina V; Bruno G; Tagliabue M; Maccario M; Bertaina S; Zumpano E; Arvat E; Ghigo E; Camanni F
    Horm Metab Res; 1997 Apr; 29(4):180-3. PubMed ID: 9178028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
    Ismail IS; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90.
    Carmichael JD; Danoff A; Milani D; Roubenoff R; Lesser ML; Livote E; Reitz RE; Ferris S; Kleinberg DL
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):169-77. PubMed ID: 16886956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone in type I diabetic and healthy man.
    Schaper NC
    Acta Endocrinol (Copenh); 1990; 122 Suppl 2():1-47. PubMed ID: 2110412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma growth hormone in diabetic and nondiabetic subjects during the glucose clamp.
    Sharp PS; Mohan V; Maneschi F; Vitelli F; Cloke HR; Burrin JM; Kohner EM
    Metabolism; 1987 Jan; 36(1):71-5. PubMed ID: 2879210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
    Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II Diabetic patients.
    Giustina A; Bresciani E; Tassi C; Girelli A; Valentini U
    Metabolism; 1994 Jul; 43(7):893-8. PubMed ID: 8028515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects.
    Tanaka Y; Atsumi Y; Asahina T; Hosokawa K; Matsuoka K; Kinoshita J; Onuma T; Kawamori R
    Diabetes Care; 1998 Jul; 21(7):1133-7. PubMed ID: 9653608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinopathy, neuropathy and nephropathy in non-insulin-dependent diabetic patients.
    Tai TY; Tseng CH; Sung SM; Huang RF; Chen CZ; Tsai SH
    J Formos Med Assoc; 1991 Oct; 90(10):936-40. PubMed ID: 1685173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.
    Micić D; Macut D; Popović V; Kendereski A; Sumarac-Dumanović M; Zorić S; Dieguez C; Casanueva FF
    Metabolism; 1999 Apr; 48(4):525-30. PubMed ID: 10206449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
    Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
    J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics with or without severe microvascular lesions.
    Blickle JF; Schlienger JL; de Laharpe F; Stephan F
    Diabete Metab; 1982 Sep; 8(3):197-201. PubMed ID: 6814964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between growth factors (somatomedin-C and growth hormone) and body development, metabolic control, and retinal changes in children and adolescents with IDDM.
    Salardi S; Cacciari E; Ballardini D; Righetti F; Capelli M; Cicognani A; Zucchini S; Natali G; Tassinari D
    Diabetes; 1986 Jul; 35(7):832-6. PubMed ID: 3721066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) on serum growth hormone response in normal and obese subjects].
    Shimizu T; Inoue K
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):82-96. PubMed ID: 3084310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.